Entering text into the input field will update the search result below

Evoke Pharma plan for accelerated review of NDA for lead product candidate Gimoti now more so; shares ahead 57%

Feb. 15, 2017 11:19 AM ETEvoke Pharma, Inc. (EVOK) StockBy: Douglas W. House, SA News Editor10 Comments

Recommended For You

About EVOK Stock

SymbolLast Price% Chg
Market Cap
PE
Yield (TTM)
Rev Growth (YoY)
Prev. Close
Compare to Peers

Related Stocks

SymbolLast Price% Chg
EVOK--
Evoke Pharma, Inc.